The aim of the present study is to test the effects of EPO treatment on cognitive function, hypoglycemic symptoms, counter-regulatory hormonal responses and cortical electrical activity during mild hypoglycemia in patients with type 1 diabetes. This evidence concerns the gene EPO and type 1 diabetes mellitus.